Exploring the 'N-terminal arm' & 'Convex surface' binding Interfaces of the T3SS Chaperone-Translocator Complexes from P. aeruginosa.

One infection method widely used by many gram-negative bacteria involves a protein nanomachine called the Type Three Secretion System (T3SS). The T3SS enables the transportation of bacterial "toxins" via a proteinaceous channel that directly links the cytosol of the bacteria and host cell. The channel from the bacteria is completed by a translocon pore formed by two proteins named the major and minor translocators. Prior to pore formation, the translocator proteins are bound to a small chaperone within the bacterial cytoplasm. This interaction is crucial to effective secretion. Here we investigated the specificity of the binding interfaces of the translocator-chaperone complexes from Pseudomonas aeruginosa via the selection of peptide and protein libraries based on its chaperone PcrH. Five libraries encompassing PcrH's N-terminal and central α-helices were panned, using ribosome display, against both the major (PopB) and minor (PopD) translocator. Both translocators were shown to significantly enrich a similar pattern of WT and non-WT sequences from the libraries. This highlighted key similarities/differences between the interactions of the major and minor translocators with their chaperone. Moreover, as the enriched non-WT sequences were specific to each translocator, it would suggest that PcrH can be adapted to bind each translocator individually. The ability to evolve such proteins indicates that these molecules may provide promising anti-bacterial candidates.

[1]  Angray S. Kang,et al.  Exploring the “N-Terminal Anchor” Binding Interface of the T3SS Chaperone–Translocator Complexes from P. aeruginosa , 2023, Biochemistry.

[2]  P. Sansonetti,et al.  Structural Insights of Shigella Translocator IpaB and Its Chaperone IpgC in Solution , 2021, Frontiers in Cellular and Infection Microbiology.

[3]  Julia A Hotinger,et al.  Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components , 2021, Biomolecules.

[4]  Michael T. Stumpp,et al.  Beyond Antibodies: The DARPin® Drug Platform , 2020, BioDrugs.

[5]  E. Faure,et al.  Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host? , 2018, Front. Immunol..

[6]  S. Wagner,et al.  Bacterial type III secretion systems: a complex device for the delivery of bacterial effector proteins into eukaryotic host cells , 2018, FEMS microbiology letters.

[7]  P. Sansonetti,et al.  Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors. , 2018, Trends in microbiology.

[8]  M. Mingeot-Leclercq,et al.  Targeting the Type Three Secretion System in Pseudomonas aeruginosa. , 2016, Trends in pharmacological sciences.

[9]  M. Valls,et al.  Modification of Bacterial Effector Proteins Inside Eukaryotic Host Cells , 2016, Front. Cell. Infect. Microbiol..

[10]  John Chilton,et al.  The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update , 2016, Nucleic Acids Res..

[11]  A. Economou,et al.  Type III Secretion: Building and Operating a Remarkable Nanomachine. , 2016, Trends in biochemical sciences.

[12]  Yunhan Hong,et al.  Structure of AcrH-AopB Chaperone-Translocator Complex Reveals a Role for Membrane Hairpins in Type III Secretion System Translocon Assembly. , 2015, Structure.

[13]  T. Heyduk,et al.  Next Generation Sequencing-based analysis of RNA polymerase functions. , 2015, Methods.

[14]  S. Chakrabarti,et al.  Binding mode analysis of a major T3SS translocator protein PopB with its chaperone PcrH from Pseudomonas aeruginosa , 2014, Proteins.

[15]  Wei Zhao,et al.  A multifunctional bispecific antibody protects against Pseudomonas aeruginosa , 2014, Science Translational Medicine.

[16]  Samuel Wagner,et al.  Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells. , 2014, Annual review of microbiology.

[17]  P. Sansonetti,et al.  Type III secretion system , 2014, Current Biology.

[18]  F. Accurso,et al.  Anti‐PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection , 2014, Pediatric pulmonology.

[19]  J. Simorre,et al.  Membrane and Chaperone Recognition by the Major Translocator Protein PopB of the Type III Secretion System of Pseudomonas aeruginosa* , 2013, The Journal of Biological Chemistry.

[20]  B. Raymond,et al.  Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors. , 2013, Trends in microbiology.

[21]  Dong Xu,et al.  Toward optimal fragment generations for ab initio protein structure assembly , 2013, Proteins.

[22]  S. Lory,et al.  Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia. , 2012, American journal of respiratory and critical care medicine.

[23]  A. Boyle,et al.  LcrH, a Class II Chaperone from the Type Three Secretion System, Has a Highly Flexible Native Structure* , 2012, The Journal of Biological Chemistry.

[24]  Yang Zhang,et al.  Ab initio protein structure assembly using continuous structure fragments and optimized knowledge‐based force field , 2012, Proteins.

[25]  H. Niemann,et al.  Crystal structure of the Yersinia enterocolitica type III secretion chaperone SycD in complex with a peptide of the minor translocator YopD , 2012, BMC Structural Biology.

[26]  B. Geisbrecht,et al.  Binding affects the tertiary and quaternary structures of the Shigella translocator protein IpaB and its chaperone IpgC. , 2012, Biochemistry.

[27]  E. Komives,et al.  Visualization of the nanospring dynamics of the IκBα ankyrin repeat domain in real time , 2011, Proceedings of the National Academy of Sciences.

[28]  M. Kolbe,et al.  Combination of Two Separate Binding Domains Defines Stoichiometry between Type III Secretion System Chaperone IpgC and Translocator Protein IpaB , 2010, The Journal of Biological Chemistry.

[29]  A. Dessen,et al.  Structural Basis of Chaperone Recognition of Type III Secretion System Minor Translocator Proteins* , 2010, The Journal of Biological Chemistry.

[30]  A. Hauser The type III secretion system of Pseudomonas aeruginosa: infection by injection , 2009, Nature Reviews Microbiology.

[31]  K. Leung,et al.  Mapping of the chaperone AcrH binding regions of translocators AopB and AopD and characterization of oligomeric and metastable AcrH‐AopB‐AopD complexes in the type III secretion system of Aeromonas hydrophila , 2009, Protein science : a publication of the Protein Society.

[32]  M. Kolbe,et al.  IpaB–IpgC interaction defines binding motif for type III secretion translocator , 2009, Proceedings of the National Academy of Sciences.

[33]  Elizabeth A Komives,et al.  Pre-folding IkappaBalpha alters control of NF-kappaB signaling. , 2008, Journal of molecular biology.

[34]  D. Heinz,et al.  Structure of the Yersinia enterocolitica type III secretion translocator chaperone SycD. , 2007, Journal of molecular biology.

[35]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[36]  B. Finlay,et al.  Type III Secretion Systems and Disease , 2007, Clinical Microbiology Reviews.

[37]  Hans Wolf-Watz,et al.  Protein delivery into eukaryotic cells by type III secretion machines , 2006, Nature.

[38]  Sophie E Jackson,et al.  Local and long-range stability in tandemly arrayed tetratricopeptide repeats. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Patrice Gouet,et al.  ESPript: analysis of multiple sequence alignments in PostScript , 1999, Bioinform..

[40]  Angray S. Kang,et al.  Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display. , 2012, Human antibodies.